Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia.

Van Dorn RA, Swanson JW, Swartz MS, Elbogen EB.

Ment Health Serv Res. 2005 Jun;7(2):123-34.

PMID:
15974158
2.

Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.

Mallinger JB, Lamberti SJ.

J Ment Health Policy Econ. 2007 Mar;10(1):15-22.

PMID:
17417044
3.

Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics.

Scheller-Gilkey G, Woolwine BJ, Cooper I, Gay O, Moynes KA, Miller AH.

Am J Drug Alcohol Abuse. 2003 Aug;29(3):553-66.

PMID:
14510040
4.

Excessive antipsychotic dosing in 2 U.S. State hospitals.

Diaz FJ, De Leon J.

J Clin Psychiatry. 2002 Nov;63(11):998-1003.

PMID:
12444813
5.

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia.

Ascher-Svanum H, Nyhuis AW, Faries DE, Ball DE, Kinon BJ.

BMC Psychiatry. 2010 Jan 28;10:11. doi: 10.1186/1471-244X-10-11.

6.

Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.

Gonzalez JM, Thompson P, Escamilla M, Araga M, Singh V, Farrelly N, Thase ME, Miklowitz DJ, Bowden CL.

Psychopharmacol Bull. 2007;40(1):31-46.

PMID:
17285094
8.

Program-level predictors of antipsychotic medication adherence among parolees.

Farabee D, Shen H, Sanchez S.

Int J Offender Ther Comp Criminol. 2004 Oct;48(5):561-71.

PMID:
15358931
10.
11.

Racial disparity in the pharmacological management of schizophrenia.

Kreyenbuhl J, Zito JM, Buchanan RW, Soeken KL, Lehman AF.

Schizophr Bull. 2003;29(2):183-93.

PMID:
14552495
12.

Antipsychotic prescribing patterns in the Texas prison system.

Baillargeon J, Contreras SA.

J Am Acad Psychiatry Law. 2001;29(1):48-53.

PMID:
11302386
13.

Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.

Aparasu RR, Jano E, Johnson ML, Chen H.

Am J Geriatr Pharmacother. 2008 Oct;6(4):198-204. doi: 10.1016/j.amjopharm.2008.10.003.

PMID:
19028375
14.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

15.

The effects of race and comorbidity on clinical diagnosis in patients with psychosis.

Strakowski SM, Shelton RC, Kolbrener ML.

J Clin Psychiatry. 1993 Mar;54(3):96-102.

PMID:
8096843
16.

Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia.

Cooper D, Moisan J, Grégoire JP.

J Clin Psychiatry. 2007 Jun;68(6):818-25.

PMID:
17592904
17.

Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL; Cost Subcommittee of the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study Group.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):449-58. doi: 10.1097/QAI.0b013e3181642244.

PMID:
18197121
18.

Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.

Diatta T, Blazejewski S, Portier A, Lignot S, Quesnot A, Moore N, Fourrier-Réglat A.

Fundam Clin Pharmacol. 2007 Aug;21(4):371-8.

PMID:
17635175
19.

Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.

Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC.

Psychiatr Serv. 2007 Apr;58(4):489-95.

20.

Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.

Wheeler AJ.

Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.

PMID:
18477732

Supplemental Content

Support Center